Drs Chan and Hunter discuss asciminib in first-line CML, OPTIC trial data on ponatinib dosing, mutational testing, and stem cell transplant strategies.
Intermountain Healthcare | Strategic Alliance Partners
Latest from Intermountain Healthcare
ASCO has released a research statement outlining 4 recommendations to decentralize clinical trials and improve patient access to these studies.
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Breakthrough Device Designation to Natera’s Multi-Cancer Early Detection Assay
2
FDA Approves Atezolizumab Plus Chemo for Stage III dMMR Colon Cancer
3
Targeted Approaches in Pancreatic Cancer, Chemo Intensification in CRC Take Center Stage as Key GI Oncology Presentations at ESMO 2026
4
Next-Generation NAMPT Inhibitors Aim to Revive a Stalled Target in AML and MDS
5